Loading...
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes
Assessing the phenotypic diversity underlying tumour progression requires the identification of variations in the respective molecular interaction networks. Here we report proof-of-concept for a platform called poly-ligand profiling (PLP) that surveys these system states and distinguishes breast can...
Saved in:
Published in: | Nat Commun |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Nature Publishing Group UK
2018
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5865185/ https://ncbi.nlm.nih.gov/pubmed/29572535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-03631-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|